作者
Markus Ketteler, Philipp Bongartz, Ralf Westenfeld, Joachim Ernst Wildberger, Andreas Horst Mahnken, Roland Böhm, Thomas Metzger, Christoph Wanner, Willi Jahnen-Dechent, Jürgen Floege
发表日期
2003/3/8
期刊
The Lancet
卷号
361
期号
9360
页码范围
827-833
出版商
Elsevier
简介
Background
Vascular calcification is the most prominent underlying pathological finding in patients with uraemia, and is a predictor of mortality in this population. Fetuin-A (α2-Heremans Schmid glycoprotein; AHSG) is an important circulating inhibitor of calcification in vivo, and is downregulated during the acute-phase response. We aimed to investigate the hypothesis that AHSG deficiency is directly related to uraemic vascular calcification.
Methods
We did a cross-sectional study in 312 stable patients on haemodialysis to analyse the inter-relation of AHSG and C-reactive protein (CRP) and their predictive effect on all-cause and cardiovascular mortality, over a period of 32 months. Subsequently, we tested the capacity of serum to inhibit Ca×PO4 precipitation in patients on long-term dialysis (n=17) with apparent soft-tissue calcifications, and in those on short-term dialysis (n=8) without evidence of calcifications and …
引用总数
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024144664628692697866811027168514534413240442610